H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...

An estimated 23 percent of adults worldwide suffer from chronic low back pain, and as many as 84 percent of us will ...

Healing Edge recognizes that the path to wellness is unique for each individual.

Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative ...

While there's no cure for wet age-related macular degeneration (AMD), there are ways to slow the disease and help you see better for longer. But early detection and timely treatment hold the key ...

National Eye Institute: “Treatments for Wet AMD (Advanced Neovascular AMD),” “Injections to Treat Eye Conditions.” CDC: “Prevalence of Age-Related Macular Degeneration (AMD).” ...

Obeticholic acid, which is marketed as Ocaliva as a treatment for a type of liver disease known as primary biliary cholangitis, has come under scrutiny recently. Although the US Food and Drug ...

With early detection and personalised therapies, Artificial Intelligence (AI) can make a significant mark for the treatment of heart diseases in India, said experts on Sunday. Heart disease is a ...

Monopar Therapeutics has secured an exclusive global license from Alexion Pharmaceuticals to develop and commercialize ALXN-1840, a promising treatment for Wilson disease, following a successful ...

Agomab’s lead candidate is being investigated as a treatment for patients with fibrostenosing Crohn’s disease (FSCD). Credit: Hananeko_Studio via Shutterstock. Agomab Therapeutics has secured $89m in ...

type TTR, addressing the underlying cause of the disease. It is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults. HELIOS-B was a ...